MD ANDERSON CANCER CENTER AND ADAPTIMMUNE FORM STRATEGIC ALLIANCE TO ADVANCE DEVELOPMENT OF IMMUNOTHERAPIES TARGETING MULTIPLE CANCERS
Categories
Adaptimmune Therapeutics and The University of Texas MD Anderson Cancer Center announced today they have entered into a multi-year strategic alliance designed to expedite the development of novel adoptive T-cell therapies for multiple types of cancer.
http://www.newswise.com/articles/md-anderson-cancer-center-and-adaptimmune-form-strategic-alliance-to-advance-development-of-immunotherapies-targeting-multiple-cancers